Achieve Life Sciences, Inc.

ACHV
$7.94 (- $0.05 - 0.63%)
Last updated: 2026-08-25 09:41 UTC
ACHV Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS0044682039
CUSIP004468203
Market Price7.94
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.35
Market Cap$229.4M
Book Value0.64
Price to Book6.777
Beta1.7
52w High5.78
52w Low1.84
Next Earnings DateN/A

Achieve Life Sciences, Inc. trades under ticker ACHV on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US0044682039, CUSIP 004468203. Also searched as Achieve Life Sciences.

Related researchACHV stock priceACHV share price004468203Achieve Life Sciences stockAchieve Life Sciences share price
About the Company
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Price History